The study focuses on how mechanical stretching of liver sinusoidal endothelial cells (LSECs) after partial hepatectomy (surgical removal of a part of the liver) triggers liver regeneration by promoting hepatocyte (liver cell) proliferation. When part of the liver is removed, blood flow per unit of liver volume increases, causing the liver's tiny blood vessels (sinusoids) to stretch.
The study focuses on how mechanical stretching of liver sinusoidal endothelial cells (LSECs) after partial hepatectomy (surgical removal of a part of the liver) triggers liver regeneration by promoting hepatocyte (liver cell) proliferation. When part of the liver is removed, blood flow per unit of liver volume increases, causing the liver's tiny blood vessels (sinusoids) to stretch. This stretch acts as a signal for regeneration.
A key finding was the role of a protein called HB-EGF (heparin-binding EGF-like growth factor), which is crucial for hepatocyte proliferation. The mechanical stretch of LSECs causes them to produce HB-EGF through a process called "mechanotransduction," where physical forces are converted into biochemical signals. This process depends on YAP (Yes-associated protein), which moves into the cell nucleus and activates genes like *Hbegf* that promote HB-EGF production.
YAP's nuclear entry happens via two mechanisms: 1) passive entry through expanded nuclear pores due to F-actin polymerization, and 2) active transport assisted by a protein called BAG3. β1-integrin, a receptor on LSECs, acts as the key mechanosensor that detects the stretch and starts this signaling cascade.
The HB-EGF secreted by stretched LSECs activates EGFR signaling in hepatocytes, stimulating their proliferation and aiding liver recovery. This "mechanocrine" process—mechanical forces triggering biochemical signals—links blood flow changes to liver regeneration, highlighting a novel pathway for understanding liver repair.
Introduction: Intrahepatic cholangiocarcinoma (ICC) is an aggressive primary liver cancer with poor prognosis and limited treatment options. While ICC has traditionally been considered a malignancy of biliary epithelial cells, increasing evidence suggests that hepatocytes can...
Introduction: Liver fibrosis is the key determinant of long-term outcomes in metabolic dysfunction-associated steatohepatitis (MASH). Activated hepatic stellate cells (HSCs) drive fibrogenesis, but effective antifibrotic therapies remain unavailable. This study investigated whether blocking the succinate–GPR91...
Introduction: The progression from metabolic dysfunction-associated fatty liver (MAFL) to metabolic dysfunction-associated steatohepatitis (MASH) is driven by complex interactions between hepatocytes and immune cells. This study identifies a novel spatial mechanism in the periportal (PP)...
Introduction: Cardiovascular–Kidney–Metabolic (CKM) syndrome recognizes the close interaction between obesity, type 2 diabetes, chronic kidney disease, and cardiovascular disease. This review highlights the emerging role of the gut microbiome, particularly butyrate-producing bacteria, as a central...
• Small intestinal adenocarcinoma (SIA) is a rare gastrointestinal cancer with limited disease-specific prognostic biomarkers and generally poor outcomes. • This nationwide Dutch population-based study evaluated whether three routinely available immunohistochemical markers—CK7, CK20, and CDX2—have...
Introduction: Metabolic dysfunction–associated steatotic liver disease (MASLD) is closely linked to insulin resistance and type 2 diabetes, with the liver traditionally viewed as a key regulator of blood glucose through hepatic glucose production. However, emerging...
We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.